https://www.selleckchem.com/pr....oducts/Tranilast.htm
Recombinant activated factor VIIa (rVIIa) is used off-label for refractory bleeding after cardiac surgery. This study reviewed the indications, usage rates, and complications of rVIIa. A retrospective case-control observational study. A single quaternary pediatric hospital. All children undergoing cardiac surgery with cardiopulmonary bypass over a three-year period. Administration of rVIIa as rescue therapy for refractory bleeding after weaning from cardiopulmonary bypass. Onethousand, five hundred fifteen cardiopulmonary bypass proce
Me gusta
Comentario
Compartir
